Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 6/2007

01-06-2007 | Case Report

Camptocormia as a clinical manifestation of mitochondrial myopathy

Authors: José A. Gómez-Puerta, Pilar Peris, Josep M. Grau, M. Angeles Martinez, Núria Guañabens

Published in: Clinical Rheumatology | Issue 6/2007

Login to get access

Abstract

Camptocormia is an unusual condition characterized by a progressive weakness of the extensor muscles of the spine that cause an involuntary truncal flexion. Occasionally, camptocormia can be the clinical manifestation of an underlying myopathy, including inflammatory or metabolic myopathies. We present a case of a 78-year-old female with camptocormia associated with a mitochondrial myopathy. Additionally, we review the clinical characteristics of three similar, previously reported cases.
Literature
1.
Umapathi T, Chaudhry V, Cornblath D, Drachman D, Griffin J, Kuncl R (2002) Head drop and camptocormia. J Neurol Neurosurg Psychiatry 73:1–7CrossRefPubMed
2.
Poullin P, Daumen-Legre V, Serratrice G (1993) Camptocormia in the elderly patient: myopathy or muscular dystonia? Rev Rhum Ed Fr 60:159–161PubMed
3.
Delcey V, Hachulla E, Michon-Pasturel U, Queyrel V, Hatron PY, Boutry N et al (2002) Camptocormia revealing axial myopathy. Concerning seven observations. Rev Med Interne 23:144–154PubMedCrossRef
4.
Schabitz WR, Glatz K, Schuhan C, Sommer C, Berger C, Schwaninger M et al (2003) Severe forward flexion of the trunk in Parkinson’s disease: focal myopathy of the paraspinal muscles mimicking camptocormia. Mov Disord 18:408–414CrossRefPubMed
5.
6.
Pearce JM (2005) A note on bent spines: ‘camptocormia’ and ‘head ptosis’. Eur Neurol 53:103–105CrossRefPubMed
7.
Karras D, Vassilakos J, Kassimos D (1996) Camptocormia or cormoptosis? The etymology of the word. Ann Rheum Dis 55:858PubMedCrossRef
8.
Laroche M, Delisle MB, Aziza R, Lagarrigue J, Mazieres B (1995) Is camptocormia a primary muscular disease? Spine 20:1011–1016PubMedCrossRef
9.
Grau JM, Casademont J, Cardellach F, Fernandez-Sola J (1995) Aging and muscle mitochondrial abnormalities. Ann Neurol 38:273–274CrossRefPubMed
10.
Azher SN, Jankovic J (2005) Camptocormia: pathogenesis, classification, and response to therapy. Neurology 65:355–359PubMedCrossRef
11.
Nandi D, Parkin S, Scott R, Winter JL, Joint C, Gregory R (2002) Camptocormia treated with bilateral pallidal stimulation. J Neurosurg 97:461–466PubMedCrossRef
Metadata
Title
Camptocormia as a clinical manifestation of mitochondrial myopathy
Authors
José A. Gómez-Puerta
Pilar Peris
Josep M. Grau
M. Angeles Martinez
Núria Guañabens
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0259-5

Other articles of this Issue 6/2007

Clinical Rheumatology 6/2007 Go to the issue

Case Report

Pachydermodactyly: four additional cases

Case Report

Leukocytapheresis for the treatment of refractory systemic-onset juvenile idiopathic arthritis

Case Report

Regional transient osteoporosis of the foot and vitamin C deficiency

Case Report

Catastrophic antiphospholipid syndrome in a 7-year-old girl

Case Report

The occurrence of systemic lupus erythematosus in an asymptomatic carrier of human T-cell lymphotropic virus type I

Case Report

Infliximab in Takayasu arteritis: a safe alternative?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits